Clever Leaves Announces Commitment to the University of Missouri to Provide CBD Isolate at No Cost Under Project Change Lives Campaign

This project will be one of the first sponsored research partnerships under Clever Leaves’ recently announced Project Change Lives Campaign, whereby the Company has pledged to contribute up to US $25 million retail value of medical cannabis products to any eligible U.S. organization in order to help advance scientific research into the medical benefits of cannabinoids.

Clever Leaves Logo

Clever Leaves to Hold Second Quarter 2021 Conference Call on August 12, 2021 at 5:00 p.m. ET

NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, will hold a conference call on Thursday, August 12, 2021 at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2021. The Company will provide its financial results in a press release prior to the conference call.